Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. ProMIS Neurosciences, Inc.
  6. News
  7. Summary
    PMN   CA74346M1095

PROMIS NEUROSCIENCES, INC.

(PMN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about PROMIS NEUROSCIENCES, INC.
06/09PROMIS NEUROSCIENCESá : congratulates Biogen on FDA accelerated approval of aduc..
AQ
06/08PROMIS NEUROSCIENCESá : congratulates Biogen on FDA accelerated approval of aduc..
PU
06/07PROMIS NEUROSCIENCESá : up 30% on FDA Approval of Biogen's Aducanumab
MT
06/03PROMIS NEUROSCIENCESá : Files preliminary short form base shelf prospectus
PU
05/27PROMIS NEUROSCIENCESá : appoints renowned scientist, Dr. David Wishart as Chief ..
PU
05/25UPDATE : ProMIS Neurosciences Up 8.1% As Says initiated Commercialization of COV..
MT
05/25PROMIS NEUROSCIENCESá : Says initiated Commercialization of COVID-19 Serology As..
MT
05/25PROMIS NEUROSCIENCES BRIEF : Says initiated Commercialization of COVID-19 Serolo..
MT
05/25PROMIS NEUROSCIENCESá : initiates commercialization of COVID-19 serology assay
AQ
05/24PROMIS NEUROSCIENCESá : re-initiates path to IND for PMN310 with producer cell l..
AQ
05/21PROMIS NEUROSCIENCESá : re-initiates path to IND for PMN310 with producer cell l..
AQ
05/14PROMIS NEUROSCIENCESá : Announces First Quarter 2021 Results
AQ
05/12ProMIS Neurosciences appoints renowned neuroscientist, Dr. Rudolph Tanzi, as ..
GL
03/31PROMIS NEUROSCIENCESá : Announces Fiscal Year 2020 Results
PU
03/23PROMIS NEUROSCIENCESá : Completes US$7M Financing with Distinguished Group of Bo..
AQ
More most relevant news
All news about PROMIS NEUROSCIENCES, INC.
06/09PROMIS NEUROSCIENCESá : congratulates Biogen on FDA accelerated approval of aduc..
AQ
06/08PROMIS NEUROSCIENCESá : congratulates Biogen on FDA accelerated approval of aduc..
PU
06/07PROMIS NEUROSCIENCESá : up 30% on FDA Approval of Biogen's Aducanumab
MT
06/03PROMIS NEUROSCIENCESá : Files preliminary short form base shelf prospectus
PU
05/27PROMIS NEUROSCIENCESá : appoints renowned scientist, Dr. David Wishart as Chief ..
PU
05/25UPDATE : ProMIS Neurosciences Up 8.1% As Says initiated Commercialization of COV..
MT
05/25PROMIS NEUROSCIENCESá : Says initiated Commercialization of COVID-19 Serology As..
MT
05/25PROMIS NEUROSCIENCES BRIEF : Says initiated Commercialization of COVID-19 Serolo..
MT
05/25PROMIS NEUROSCIENCESá : initiates commercialization of COVID-19 serology assay
AQ
05/24PROMIS NEUROSCIENCESá : re-initiates path to IND for PMN310 with producer cell l..
AQ
More news
News in other languages on PROMIS NEUROSCIENCES, INC.

- No features available -

More news
Press releases
06/09PROMIS NEUROSCIENCESá : congratulates Biogen on FDA accelerated approval of aduc..
AQ
06/08PROMIS NEUROSCIENCESá : congratulates Biogen on FDA accelerated approval of aduc..
PU
06/03PROMIS NEUROSCIENCESá : Files preliminary short form base shelf prospectus
PU
05/27PROMIS NEUROSCIENCESá : appoints renowned scientist, Dr. David Wishart as Chief ..
PU
05/25PROMIS NEUROSCIENCESá : initiates commercialization of COVID-19 serology assay
AQ
More press releases
Upcoming event on PROMIS NEUROSCIENCES, INC.